Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time Restricted Eating in Early Stage Breast Cancer
NCT05327608Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Jul 2022
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Thomas Jefferson University. Primary endpoint: Proportion of patients who can adhere to time restricted eating (TRE) >= 70% of days at 4 months. Started Jul 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05327608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327608.